Valuation : IXICO plc

Market Cap 1.64Cr 2.21Cr 1.9Cr 1.79Cr 3.06Cr 208.79Cr 3.07Cr 21Cr 8.2Cr 107.06Cr 8.29Cr 8.12Cr 345.23Cr P/E 2026 *
-5.36x
P/E 2027 * -5.77x
Enterprise Value 61.54L 83.18L 71.59L 67.37L 1.15Cr 79Cr 1.15Cr 7.96Cr 3.09Cr 40Cr 3.12Cr 3.05Cr 129.9Cr EV / Sales 2026 *
0.77x
EV / Sales 2027 * 1.14x
Free-Float
89.22%
Yield 2026 *
-
Yield 2027 * -
1 week-3.23%
Current month-3.23%
1 month-6.25%
3 months-13.29%
6 months-3.85%
Current year-36.17%
1 week 7
Extreme 7
8
1 month 7
Extreme 7
8.5
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
15
3 years 6.26
Extreme 6.26
21
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 19/08/2024
Director of Finance/CFO 50 21/08/2019
Chief Tech/Sci/R&D Officer - 01/06/2025
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 21/08/2019
Director/Board Member 60 21/01/2022
Date Insider Type Main position Quantity % Market Cap. Importance
15/07/26 Buy

Chairman

50,006 0.0228%
13/06/25 Free 3,50,000 0.3777%
13/06/25 Free 3,50,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.23%-36.71%-63.05% 2.21Cr
-2.54%-2.84%-1.77%+14.72% 4.89TCr
-0.40%+1.03%+418.57%+523.39% 4.5TCr
-1.42%+2.30%+42.67%+21.22% 4.41TCr
-1.22%-2.31%+4.82%+74.90% 4.07TCr
+0.53%-1.36%+16.87%+47.12% 3.35TCr
-0.21%+9.14% - - 1.78TCr
-0.35%-1.56%+21.42%+123.04% 1.65TCr
-1.01%+0.50%+13.91%+31.45% 1.47TCr
-1.65%-1.03%+75.93%+41.22% 1.38TCr
Average -0.83%+0.16%+61.74%+90.45% 2.75TCr
Weighted average by Cap. -1.03%+0.11%+89.41%+127.91%

Financials

2026 *2027 *
Net sales 80L 1.08Cr 93.07L 87.58L 1.5Cr 102.14Cr 1.5Cr 10Cr 4.01Cr 52Cr 4.06Cr 3.97Cr 168.88Cr 90L 1.22Cr 1.05Cr 98.53L 1.68Cr 114.91Cr 1.69Cr 12Cr 4.51Cr 59Cr 4.56Cr 4.47Cr 189.99Cr
Net income -21.43L -28.97L -24.93L -23.46L -40.07L -27Cr -40.19L -2.77Cr -1.07Cr -14Cr -1.09Cr -1.06Cr -45Cr -28.01L -37.86L -32.59L -30.66L -52.38L -36Cr -52.54L -3.62Cr -1.4Cr -18Cr -1.42Cr -1.39Cr -59Cr
Net Debt -1.02Cr -1.38Cr -1.19Cr -1.12Cr -1.91Cr -130.23Cr -1.91Cr -13Cr -5.12Cr -67Cr -5.17Cr -5.06Cr -215.33Cr -61L -82.45L -70.97L -66.78L -1.14Cr -78Cr -1.14Cr -7.89Cr -3.06Cr -40Cr -3.09Cr -3.03Cr -128.77Cr
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
04/26/04 GBX 7.500 0.00% 12,823
03/26/03 GBX 7.500 0.00% 57,826
02/26/02 GBX 7.500 0.00% 20,000
01/26/01 GBX 7.500 -3.23% 70,164
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0750GBP
Average target price
0.2600GBP
Spread / Average Target
+246.67%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!